Latest 10-K annual reports

Orthofix Medical Inc. reported 2025 net sales of $822.3 million, a 2.9% increase, alongside strategic discontinuation of M6 artificial disc product lines and ongoing legal proceedings involving former executives.

Armstrong World Industries, Inc. reported a significant increase in net sales and operating income for 2025, driven by strategic acquisitions and favorable average unit value.

Life Time Group Holdings, Inc. achieved record revenue and significant net income growth in 2025, driven by strong membership engagement and strategic expansion.

Apellis Pharmaceuticals achieved its first net income of $22.4 million in 2025, driven by strong licensing revenue and continued commercialization of SYFOVRE and EMPAVELI, despite a decline in SYFOVRE sales.

Innovative Industrial Properties, Inc. reports significant financial declines and a going concern warning due to debt maturity, while strategically expanding into life science investments.

Clarivate Plc reported a 4% revenue decline in 2025 to $2.46 billion, alongside a significantly reduced net loss and increased free cash flow, as it executes its Value Creation Plan focused on AI innovation and business streamlining.

World Kinect Corporation reported a significant net loss of $614.4 million for fiscal year 2025, primarily driven by substantial goodwill impairments and restructuring costs in its land segment, despite growth in aviation gross profit.

Dream Finders Homes reports a decline in net income and homebuilding gross margin for 2025 amidst macroeconomic challenges, while strategically expanding its market presence and financial services.

Landstar System reports a 2% revenue decrease and significant impairment charges in fiscal year 2025, impacting net income and EPS.

Monarch Casino & Resort, Inc. announced a significant increase in net income and diluted EPS for 2025, driven by casino revenue growth, despite ongoing litigation costs related to its Black Hawk expansion.

Valmont Industries, Inc. reported a slight increase in net sales for fiscal year 2025, driven by Infrastructure growth but offset by declines in Agriculture, alongside significant impairment charges.

Paymentus Holdings, Inc. announced robust financial results for fiscal year 2025, driven by significant transaction volume growth and increased profitability, despite moderating inflation.

Diversified Healthcare Trust reported a reduced net loss and increased total NOI in 2025, driven by strong SHOP performance and strategic asset sales, despite a decline in FFO and negative operating cash flow.

Primoris Services Corporation announced robust financial results for the fiscal year ended December 31, 2025, with significant revenue growth across both its Utilities and Energy segments.

U.S. Bancorp reports significant earnings growth, robust capital, and strategic acquisition plans for 2025, alongside detailed regulatory and risk disclosures.

Benchmark Electronics reported a significant drop in net income for fiscal year 2025, despite flat overall sales, driven by increased restructuring charges and a higher effective tax rate.

Park National Corporation announced a significant increase in net income for 2025, alongside a strategic acquisition that pushed its consolidated assets past $10 billion, triggering new regulatory oversight.

Trustmark Corporation reported record net income and strong revenue growth in 2025, driven by robust loan and deposit expansion, an improved net interest margin, and increased profitability across its core banking and wealth management segments.

Summit Therapeutics' Biologics License Application for ivonescimab in EGFR-mutated NSCLC was accepted by the FDA, despite the primary analysis not achieving statistically significant overall survival.

Cincinnati Financial Corporation delivered robust financial results in 2025, surpassing its value creation ratio target with significant premium growth and investment income, despite increased catastrophe losses.

V2X, Inc. announced a 3.7% revenue increase and a 22.0% rise in operating income for the fiscal year ended December 31, 2025, driven by program ramp-ups and cost control.

Invesco Mortgage Capital Inc. reported a significant increase in net income for 2025, driven by net gains on investments and improved net interest income, despite losses on derivative instruments.

Veris Residential, Inc. reported a significant turnaround in 2025 with net income of $78.9 million, driven by strategic asset dispositions and debt reduction, while also announcing a definitive merger agreement to be acquired for $19.00 per share in cash.

IPG Photonics reported a 2.7% revenue increase in 2025 to $1.004 billion, alongside improved gross margins and a return to net income, despite ongoing geopolitical challenges and a patent infringement lawsuit.

Vir Biotechnology strengthens its pipeline with a global strategic collaboration for prostate cancer candidate VIR-5500 and an exclusive commercial license for its chronic hepatitis delta treatment in Europe, Australia, and New Zealand, while reporting a net loss of $438.0 million for 2025.

Ultra Clean Holdings, Inc. reported a net loss of $181.2 million for fiscal year 2025, primarily due to a significant goodwill impairment charge and a slight revenue decline.

ImmunityBio reports significant revenue growth and multiple international approvals for its lead immunotherapy ANKTIVA, while navigating substantial operating losses, ongoing legal disputes, and the need for additional financing.

Hims & Hers Health, Inc. announced significant revenue and Adjusted EBITDA growth for 2025, alongside international expansion and new product launches, but faces increasing regulatory and legal challenges.

Ovintiv Inc. reported net earnings of $1,242 million for fiscal year 2025, driven by strategic acquisitions and operational efficiencies, while navigating lower oil prices and divesting non-core assets.

ACV Auctions Inc. announced significant revenue growth and a more than doubling of Adjusted EBITDA in its 2025 annual report, despite a net loss and a substantial charge from a dealer bankruptcy.